Ambrosia Biosciences
Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders
$100MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders
Provides continuous vulnerability remediation for software supply chain security
Pitching Boulder Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room